Publication: Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase
Issued Date
2009-04-03
Resource Type
ISSN
10902104
0006291X
0006291X
Other identifier(s)
2-s2.0-62149105534
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biochemical and Biophysical Research Communications. Vol.381, No.2 (2009), 144-147
Suggested Citation
N. Sriwilaijaroen, S. Boonma, P. Attasart, J. Pothikasikorn, S. Panyim, W. Noonpakdee Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase. Biochemical and Biophysical Research Communications. Vol.381, No.2 (2009), 144-147. doi:10.1016/j.bbrc.2009.01.165 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/27247
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase
Other Contributor(s)
Abstract
Acetylation and deacetylation of histones play important roles in transcription regulation, cell cycle progression and development events. The steady state status of histone acetylation is controlled by a dynamic equilibrium between competing histone acetylase and deacetylase (HDAC). We have used long PfHDAC-1 double-stranded (ds)RNA to interfere with its cognate mRNA expression and determined the effect on malaria parasite growth and development. Chloroquine- and pyrimethamine-resistant Plasmodium falciparum K1 strain was exposed to 1-25 μg of dsRNA/ml of culture for 48 h and growth was determined by [3H]-hypoxanthine incorporation and microscopic examination. Parasite culture treated with 10 μg/ml pfHDAC-1 dsRNA exhibited 47% growth inhibition when compared with either untreated control or culture treated with an unrelated dsRNA. PfHDAC-1 dsRNA specifically blocked maturation of trophozoite to schizont stages and decreased PfHDAC-1 transcript 44% in treated trophozoites. These results indicate the potential of HDAC-1 as a target for development of novel antimalarials. © 2009 Elsevier Inc. All rights reserved.